Guidelines for the Use of Laser, anti-VEGF, or Steroids in DME

摘要

Introduction: Diabetic macular edema (DME) is the most common cause of visual impairment in diabetic patients, causing symptoms that range from blurring of central vision to acute vision loss. If DME is left untreated, more than 50% of patients lose >2 lines of visual acuity (VA) within 2 years.As the population of people with diabetes increases, the annual incidence of diagnosed DME is consequently increasing. DME can be present both in the setting of non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Although DME can develop at any stage of DR, it is directly related with duration and severity of DR. The Wisconsin Eye Survey of Diabetic Retinopathy (WESDR) study showed that the prevalence of DME twenty years after the diagnosis was about 30%.Strict control of blood glucose and blood pressure is mandatory in an attempt to reduce the incidence and the progression of DME.